Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000912282-25-000055·Charmquark TWEE
Schedule 13G ownership disclosure
IMMUNOPRECISE ANTIBODIES LTD
Common Shares, no par value · CUSIP: 45257F200
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Charmquark TWEE
Shares: 1,828,365 · Class: 5.8%
- Charmquark EEN
Shares: 1,828,365 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000912282-25-000055
- Form type
- SCHEDULE 13G/A
- Filer
- Charmquark TWEE
- CIK
- CIK 1930122
- Filed
- Jan 24, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership